Dose-Ranging Trial of Enoxaparin for Unstable Angina: Results of TIMI 11A 11A list of the participating investigators and clinical centers for the TIMI 11A trial appears in the Appendix A.
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Alterations of Coagulation and Fibrinolytic and Kallikrein-Kinin Systems in the Acute and Postacute Phases in Patients With Unstable Angina PectorisCirculation, 1995
- Treatment of Deep Venous Thrombosis With Low-Molecular-Weight HeparinsArchives of internal medicine (1960), 1995
- Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.Circulation, 1994
- Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina.Circulation, 1993
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Low molecular weight heparinBlood, 1992
- Effects of Unfractionated Heparin, Dermatan Sulfate and Low Molecular Weight Heparin on Vessel Wall Permeability in RabbitsaAnnals of the New York Academy of Sciences, 1989
- Practical Considerations on the Measurement of Low Molecular Weight Heparin Anti-Xa ActivitySeminars in Thrombosis and Hemostasis, 1985
- Assay of heparin in plasma using a chromogenic substrate for activated factor XThrombosis Research, 1976